ROTHER RUSSELL P.,ROTHER Russell P.,SHERIDAN DOUGLAS L.,SHERIDAN Douglas L.,TAMBURINI PAUL P.,TAMBURINI Paul P.,ZHANG YUCHUN,ZHANG Yuchun
申请号：
SI201130659
公开号：
SI2563813T1
申请日:
2011.04.29
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement-associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospholipid syndrome, asthma, lupus nephritis, Goodpastures syndrome, and chronic obstructive pulmonary disease.
